Premium Phosphosite-Specific 7TM Antibodies
Novel Tools for Your GPCR Research
Select Your Country of Delivery below

Neurotensin Receptor 2 Antibodies

Close filters
No results were found for the filter!
Citations
Validation of the Neurotensin receptor 2 in transfected HEK293 cells.
NTS2 (non-phospho-Neurotensin Receptor 2 Antibody)
The NTS2 antibody is directed against the distal end of the carboxyl-terminal tail of human Neurotensin Receptor 2. It can be used to detect total NTS2 receptors in Western blots independent of phosphorylation. The NTS2 antibody can also...
$ 400.00 *
Details
Citations
NTS2 (IHC-grade), Neurotensin Receptor 2 Antibody
NTS2 (IHC-grade), Neurotensin Receptor 2 Antibody
The NTS2 antibody is directed against the distal end of the carboxyl-terminal tail of human Neurotensin Receptor 2. It can be used to detect total NTS2 receptors in Western blots independent of phosphorylation. The NTS2 antibody can also...
$ 400.00 *
Details

The neurotensin receptor 2  (NTS2) is the specific receptor for neurotensin (NT). NTS2 can be distinguished from other NT receptors by levocabastine, a histamine H1 antagonist, which totally and selectively inhibits the binding of NT to NTS2. Cerebral administration of NT modulates dopaminergic transmission and leads to hypothermic and naloxone-independent analgesic responses. In the periphery, NT induces hypotension, decreases gastric acid secretion and activates lipid digestion. NTS2 receptors are highly abundant in parietal cells of the gastric mucosa, in neuroendocrine cells of the stomach, small and large intestine, and in cells of the exocrine pancreas.

The neurotensin receptor 2  (NTS2) is the specific receptor for neurotensin (NT). NTS2 can be distinguished from other NT receptors by levocabastine, a histamine H1 antagonist, which totally... read more »
Close window
Neurotensin Receptor 2 Antibodies

The neurotensin receptor 2  (NTS2) is the specific receptor for neurotensin (NT). NTS2 can be distinguished from other NT receptors by levocabastine, a histamine H1 antagonist, which totally and selectively inhibits the binding of NT to NTS2. Cerebral administration of NT modulates dopaminergic transmission and leads to hypothermic and naloxone-independent analgesic responses. In the periphery, NT induces hypotension, decreases gastric acid secretion and activates lipid digestion. NTS2 receptors are highly abundant in parietal cells of the gastric mucosa, in neuroendocrine cells of the stomach, small and large intestine, and in cells of the exocrine pancreas.

Recently viewed